Malaria tablets: chloroquine
Chloroquine phosphate or hydroxychloroquine sulphate (Plaquenil®)
Indication
Chloroquine phosphate or hydroxychloroquine sulphate (Plaquenil®) can be used in the prevention of malaria only in destinations where chloroquine resistance is not present. Widespread resistance in most malaria-endemic countries has led to a decline in its use.
Formulation
- one adult tablet contains 200mg hydroxychloroquine sulphate (=155 mg base).
Half- Life
- 1–2 months
Dosing schedule
- adults: 300 mg base (500 mg salt) once a week
- children >5kg: 5 mg/kg base (8.3mg/kg salt) orally once a week, up to maximum 300 mg base
- duration: once a week, to start 1-2 weeks before entering risk zone and take until 28 days after leaving.
Protection
- chloroquine-resistant P. falciparum malaria is widespread (effectively universal), but it remains effective against most P. vivax, all P. ovale, P. knowlesi and virtually all P. malariae
- chloroquine-resistant P. vivax is found in the Indonesian archipelago, the Malay Peninsula, including Myanmar, and eastward to Southern Vietnam, and may have spread further
Contra- indications
- convulsions/ epilepsy
- concomitant use with amiodarone (ventricular arrhythmias), ciclosporin (ciclosporin toxicity), digoxin (increases plasmaconcentration), mefloquine (convulsions), moxifloxacin (ventricular arrhythmias)
Precautions
- highly toxic in overdose and children are particularly susceptible
- antacids can reduce the absorption of chloroquine so it should be taken with an interval of at least four hours
Pregnancy and breastfeeding
- can be used in pregnancy and during breastfeeding.
Side effects
- potential exacerbation of psoriasis and myasthenia gravis
- severe hypoglycaemia in diabetics and non-diabetics
- gastrointestinal disturbances
- headaches
- itching (especially in African descents)
Advantages and disadvantages
limited use due to increasing resistance
Additional information
- Wikitropica: background information on malaria for medical prefessionals
- Malaria Factsheet (WHO 2022)
- About Malaria (CDC 2022)
- CDC Yellow book: Travel-Related Infectious Diseases - Malaria (CDC 2023)